» Articles » PMID: 33588833

Evaluation of Fasting Plasma Insulin and Proxy Measurements to Assess Insulin Sensitivity in Horses

Overview
Journal BMC Vet Res
Publisher Biomed Central
Date 2021 Feb 16
PMID 33588833
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Proxies are mathematical calculations based on fasting glucose and/or insulin concentrations developed to allow prediction of insulin sensitivity (IS) and β-cell response. These proxies have not been evaluated in horses with insulin dysregulation. The first objective of this study was to evaluate how fasting insulin (FI) and proxies for IS (1/Insulin, reciprocal of the square root of insulin (RISQI) and the quantitative insulin sensitivity check index (QUICKI)) and β-cell response (the modified insulin-to-glucose ratio (MIRG) and the homeostatic model assessment of β-cell function (HOMA-β)) were correlated to measures of IS (M index) using the euglycemic hyperinsulinemic clamp (EHC) in horses with insulin resistance (IR) and normal IS. A second objective was to evaluate the repeatability of FI and proxies in horses based on sampling on consecutive days. The last objective was to investigate the most appropriate cut-off value for the proxies and FI.

Results: Thirty-four horses were categorized as IR and 26 as IS based on the M index. The proxies and FI had coefficients of variation (CVs) ≤ 25.3 % and very good reliability (intraclass correlation coefficients ≥ 0.89). All proxies and FI were good predictors of the M index (r = 0.76-0.85; P < 0.001). The proxies for IS had a positive linear relationship with the M index whereas proxies for β-cell response and FI had an inverse relationship with the M index. Cut-off values to distinguish horses with IR from horses with normal IS based on the M index were established for all proxies and FI using receiver operating characteristic curves, with sensitivity between 79 % and 91 % and specificity between 85 % and 96 %. The cut-off values to predict IR were < 0.32 (RISQI), < 0.33 (QUICKI) and > 9.5 µIU/mL for FI.

Conclusions: All proxies and FI provided repeatable estimates of horses' IS. However, there is no advantage of using proxies instead of FI to estimate IR in the horse. Due to the heteroscedasticity of the data, proxies and FI in general are more suitable for epidemiological studies and larger clinical studies than as a diagnostic tool for measurement of IR in individual horses.

Citing Articles

Evaluation of an Automated Fluorescence Enzyme Immunoassay for Quantification of Equine Insulin and Comparison to Five Other Immunoassays.

Nolen-Walston R, Kulp J, Stefanovski D, van Eps A J Vet Intern Med. 2025; 39(2):e70038.

PMID: 40048611 PMC: 11884604. DOI: 10.1111/jvim.70038.


Development of a Web App to Convert Blood Insulin Concentrations among Various Immunoassays Used in Horses.

Delarocque J, Feige K, Carslake H, Durham A, Fey K, Warnken T Animals (Basel). 2023; 13(17).

PMID: 37684968 PMC: 10487020. DOI: 10.3390/ani13172704.


Investigating the Relationship Between Cardiac Function and Insulin Sensitivity in Horses: A Pilot Study.

Williams N, Furr M, Navas de Solis C, Campolo A, Davis M, Lacombe V Front Vet Sci. 2022; 9:899951.

PMID: 35873691 PMC: 9305457. DOI: 10.3389/fvets.2022.899951.

References
1.
Lindase S, Nostell K, Muller C, Jensen-Waern M, Brojer J . Effects of diet-induced weight gain and turnout to pasture on insulin sensitivity in moderately insulin resistant horses. Am J Vet Res. 2016; 77(3):300-9. DOI: 10.2460/ajvr.77.3.300. View

2.
Lindase S, Muller C, Nostell K, Brojer J . Evaluation of glucose and insulin response to haylage diets with different content of nonstructural carbohydrates in 2 breeds of horses. Domest Anim Endocrinol. 2018; 64:49-58. DOI: 10.1016/j.domaniend.2018.03.006. View

3.
Patterson-Kane J, Karikoski N, McGowan C . Paradigm shifts in understanding equine laminitis. Vet J. 2018; 231:33-40. DOI: 10.1016/j.tvjl.2017.11.011. View

4.
Warnken T, Huber K, Feige K . Comparison of three different methods for the quantification of equine insulin. BMC Vet Res. 2016; 12(1):196. PMC: 5016943. DOI: 10.1186/s12917-016-0828-z. View

5.
Durham A, Frank N, McGowan C, Menzies-Gow N, Roelfsema E, Vervuert I . ECEIM consensus statement on equine metabolic syndrome. J Vet Intern Med. 2019; 33(2):335-349. PMC: 6430910. DOI: 10.1111/jvim.15423. View